Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

Abstract

Systemic literary review of published studies informing the EULAR recommendations for the ma-nagement and therapy of rheumatoid arthritis with biological disease-modifying antirheumatic drugs published in last 10 years.

Keywords

• antitumor-necrosis-factor
• placebo-controlled trial
• interleukin-1 receptor antagonist
• receiving concomitant methotrexate
• adalimumab plus methotrexate
• randomized controlled-trial
• alpha monoclonal-antibody
• interstitial lung-disease
• phase-iii trial
• double-blind